Nishikimi, Mitsuaki
Ohshimo, Shinichiro
Nobayashi, Kiyono
Kinoshita, Takahiro
Shime, Nobuaki
Article History
Received: 23 September 2025
Accepted: 19 February 2026
First Online: 26 February 2026
Declarations
:
: Ethical approval was obtained by the Institutional Review Board of Hiroshima University.
: The IRB of Hiroshima University Hospital approved this study as minimal-risk research using data collected for routine clinical practice and waived the required for informed consent.
: TK is the founder and Chief Executive Officer of MeDiCU, Inc., which developed and maintains the OneICU database used in this analysis. The authors declare no additional relationships or conflicts of interest relevant to this study.